Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001837607-25-000005
Filing Date
2025-01-13
Accepted
2025-01-13 06:00:02
Documents
2
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 PRE 14A aeon-20250224xpre14a.htm PRE 14A 307863
2 GRAPHIC aeon-20250224xpre14a002.jpg GRAPHIC 12224
  Complete submission text file 0001837607-25-000005.txt   326027
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40021 | Film No.: 25524597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)